Travel ban on India could hamper drug imports, hike prices, say pharmacists

There are fears that restrictions on flights from India could lead to drug scarcity and sharp rise in the prices of pharmaceutical products because more than 70 per cent of active pharmaceutical ingredients (APIs) and finished drug products and vaccines are imported from India and China.